LPL Financial
AMRI

LPL Financial’s Albany Molecular Research Inc AMRI Stock Holding History

LPL Financial’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,948
Closed -$266K – 3258
2015
Q4 		$266K Buy
+13,948
New +$265K ﹤0.01% 2626
2014
Q2 		– Sell
-18,230
Closed -$339K – 2788
2014
Q1 		$339K Buy
+18,230
New +$251K ﹤0.01% 2053

Other funds holding AMRI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LPL Financial's AMRI Position: Q1 2016 in Review

LPL Financial sold out of Albany Molecular Research Inc (AMRI) in Q1 2016, closing a stake of 13,948 shares — an estimated $266K sold.

LPL Financial first reported a position in AMRI in Q1 2014 and held it in 2 quarters. The position peaked at $339K in Q1 2014. 141 funds tracked by Wall St. Rank hold AMRI as of Q1 2016.

  • LPL Financial reported no remaining Albany Molecular Research Inc position as of Q1 2016 after selling out during the quarter.
  • LPL Financial sold 13,948 Albany Molecular Research Inc shares in Q1 2016, an estimated $266K.
  • LPL Financial first reported a position in Albany Molecular Research Inc in Q1 2014 and held it in 2 quarters.
  • LPL Financial's Albany Molecular Research Inc position peaked at $339K in Q1 2014.
  • 141 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2016.

Based on LPL Financial's 13F filing for Q1 2016, filed 16 May 2016.